Macrophages participate in antibody-mediated anti-cancer responses. Blocking the SIRPα-CD47 macrophage checkpoint may be beneficial in treating cancer. From Weiskope and Weissman, mAbs 7, 303-310 (2015). Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).